We combine first-of-its-kind technology with human care to help people with diabetes and other chronic metabolic conditions lead happier, healthier lives.
We knew there was a better way to treat the chronic metabolic conditions that affect over a billion people around the world, and it would have to start with the understanding that every person is different—biologically different, psychologically different, socio-economically different, and different in their likes and dislikes. So our approach to helping people regain their metabolic health would have to be unique to the individual.
We set about defining and refining that approach, using data, AI, and human ingenuity to determine the best way to treat complex metabolic conditions, person by person. The result: the creation of Whole Body Digital Twin™, a completely individualized representation of the internal processes happening in a person’s body, and how small changes in things like nutrition, activity, and sleep can lead to long-lasting improvements. We now see how the Whole Body Digital Twin, combined with our compassionate clinical care, transforms people’s health.
Some say we prevent and reverse chronic metabolic disease like type 2 diabetes, obesity, and fatty liver. We say we help people reclaim their good health and zest for life. Our members say Twin Health changed their lives!
Twin Health was founded by Jahangir Mohammed, a serial inventor and entrepreneur, with a mission to reverse chronic diseases and help people live healthier and happier lives. Jahangir was the Founder/CEO of Jasper, which he helped build into a global market leader with Internet of Things (IoT) platforms. Currently used by over 10,000 enterprises around the world, Jasper was acquired by Cisco for $1.45B. Prior to Jasper, Jahangir was the Founder/CEO of Kineto Wireless, which pioneered the technologies to enable mobile phones to seamlessly use WiFi for voice and data. The technologies invented at Kineto became the basis for the UMA standard.
Jahangir is a prolific inventor with over 80 patents. He was named IoT Technology Pioneer at the World Economic Forum and was recognized for his visionary work and social impact by the Einstein Foundation. He was awarded an Honorary Doctorate by Concordia University, Canada.
Terry Poon co-founded Twin Health and drives the vision for technology development. He leads the development of Twin's innovative platform and unique algorithms to improve human metabolic health using IoT, machine learning, and Digital Twin technologies. Prior to Twin, Terry was VP of Engineering at Jasper Technologies, where he built global software engineering teams and served as a lead architect of the company’s IoT cloud platform. In addition, Terry led engineering efforts for Jasper’s launch in the China market, the fastest-growing in the company’s history. Prior to Jasper, Terry held engineering and management positions at Oracle.
Terry graduated from MIT with a Master's in Computer Science Engineering and BS degrees in Computer Science and Economics. He holds 10 patents in software and analytics technologies.
Maluk co-founded Twin Health and as VP of Research, he leads global trend-studies and guides the development of strategic initiatives based on research outcomes. He also runs operations for the Twin Service in India, including its launch in 2019. Prior to Twin, Maluk founded and served as President and Chairman of the MAM Group of Institutions in Tamil Nadu, India. Under his leadership, the institution grew to 10 colleges, currently educating more than 10,000 undergraduate and graduate students in engineering, architecture, business administration, and nursing.
Maluk earned his PhD from the Indian Institute of Technology Madras in the area of distributed mobile computing, and his Master of Engineering degree from National Institute of Technology Tiruchirappalli. He has published 178 research publications in various international journals and conference proceedings.
Lisa Shah, MD is responsible for US clinical operations, outcomes, and innovation to reverse diabetes and other chronic disease. She has years of hands-on experience in healthcare and innovation, from designing value-based care models to leading the implementation of new care delivery models in the practice setting. Prior to joining Twin, Lisa served as CMO for Advantia Health, Chief Innovation Officer for Sound Physicians, and SVP of Clinical Operations and Network for Evolent Health.
Lisa graduated from Duke University with a BA in English and completed medical school at the University of Medicine and Dentistry of New Jersey. At the University of Chicago, she completed her residency in Internal Medicine and Pediatrics, a post-residency health services research fellowship, and a Master's degree in Public Policy. Lisa is a member of Women of Impact in Healthcare and has received multiple awards from the Washington Business Journal, including the annual C-Suite award in 2019.
John is responsible for leading Twin Health’s US commercial strategy and growth. John has 20 years’ experience in healthcare with deep focus on value-based care transformation and risk-based contracting models. Prior to joining Twin, John was an early member of the Evolent Health growth team where he supported Evolent’s growth across Medicare, Medicaid, and commercial market segments resulting in Evolent’s IPO in 2015.
John graduated magna cum laude from the University of Georgia with a BBA in International Business.
Jennifer Bealer serves as Twin's Chief Legal Officer. Prior to that she was Executive Vice President, General Counsel and Secretary of Progyny Inc. Before Progyny Jennifer was an Associate at the law firm Ropes & Gray’s nationally-ranked healthcare practice from November 2010 to October 2017, where she gained extensive expertise in providing healthcare clients with strategic, regulatory, compliance and transaction advice.
Ms. Bealer holds a B.S. in Biology and Psychology from the Pennsylvania State University and received her J.D. from the University of Pennsylvania Law School, A.L.M from Harvard University, and Master of Bioethics from University of Pennsylvania School of Medicine.
Tom Samuelson is responsible for Twin’s finance and supply chain teams, driving Twin’s global financial strategy and ensuring our ongoing financial health and performance. Prior to Twin, Tom led financial strategy at Precigen, a publicly traded healthcare company, including financial planning & analysis (FP&A), fundraising, cash management and divestitures of Precigen’s portfolio companies. At Precigen, Tom drove turnarounds of multiple operating subsidiaries that ultimately yielded more than $250M in transaction value, an equity offering of ~$130M and a company-wide cost rationalization that reduced cash requirements by more than 50%.
Tom began his finance career in the healthcare investment banking group at J.P. Morgan where he covered biotechnology and specialty pharmaceuticals. Tom holds a bachelor’s degree in Biology, Neuroscience and Psychology from Williams College and an M.B.A. from MIT.
Toby Cosgrove, MD is the former President and Chief Executive Officer of Cleveland Clinic and currently serves as an Executive Advisor for the health system.
Dr. Cosgrove is a sought-after speaker worldwide. He has addressed the World Economic Forum Annual Meeting at Davos, Switzerland, and the Senate Health, Education, Labor and Pensions Committee, in Washington, D.C. He is regularly quoted and featured in national magazines and newspapers, including a cover story in Time, and major articles in Newsweek, the New York Times, and the Washington Post. He has appeared on CNN, Fox, MSNBC, NBC, CBS, “The Charlie Rose Show” on PBS, and other national media outlets.
The recipient of Cleveland Clinic’s Master Clinician Award, Innovator of the Year Award, and Lerner Humanitarian Award, Dr. Cosgrove is also a member of Cleveland Medical Hall of Fame and Cleveland Business Hall of Fame. In 2007 he was named Cleveland Business Executive of the Year by the Sales and Marketing Executives of Cleveland, and Castle Connolly’s National Physician of the Year. He also received the Woodrow Wilson Center Award for Public Service as well as Harvard Business School’s Award from HBS Alumni, Cleveland, and the Humanitarian Award of the Diversity Center of Northeast Ohio. Dr. Cosgrove topped Inside Business’s “Power 100” listing for Northeast Ohio, and is highly ranked among Modern Healthcare’s “100 most powerful people in healthcare” and “most powerful physician executives.”
Bruce Dunlevie has worked in the early stage technology venture capital industry for more than 30 years, and is a founder and general partner of Benchmark Capital, based in Silicon Valley. Benchmark was an early investor in numerous successful startups including eBay, Twitter, Uber, Snapchat, WeWork and Instagram.
Prior to co-founding Benchmark Capital, Mr. Dunlevie worked in investment banking at Goldman, Sachs & Co.
Mr. Dunlevie serves on the board of the Stanford Management Company, the entity which oversees the Stanford University Endowment, and he is a trustee of The Getty Trust in Los Angeles. He is a former trustee of Stanford University and of his alma mater, Rice University. He is also a Fellow Benefactor of Trinity College, University of Cambridge.
Mr. Dunlevie earned a BA in literature and history from Rice University and an MBA from Stanford University, where he was an Arjay Miller Scholar.
Kevin Johnson most recently served as president and chief executive officer of Starbucks. Kevin first joined Starbucks in 2009, serving on the company’s board of directors during a period of record-setting transformation and growth. In March 2015, Kevin took on the role of president and chief operating officer, leading the company’s global operating businesses across all geographies, as well as the core support functions of Starbucks supply chain, marketing, human resources, technology and mobile and digital platforms. He assumed the role of president and CEO in April 2017, a role he held for five years prior to retiring in April 2022. Under Kevin’s leadership, Starbucks created significant value for all stakeholders. Kevin was the architect of Starbucks Growth at Scale agenda, transforming the way Starbucks drove innovation both in stores and digitally, expanding its global reach, significantly improving the company’s performance, and delivering record results.
His career spans more than 40 years, scaling global businesses, including 16 years at Microsoft, five years as CEO of Juniper Networks, 13 years at Starbucks including five years as president and CEO. He has also served our country when in 2008, he was appointed to the National Security Telecommunication Advisory Committee where he served both presidents George W. Bush and Barack Obama.
Kevin’s commitment to innovation and following his heart extends beyond the world of business. He was a founding board member of NPower, an organization that provides nonprofits with access to technology and the skills needed to fulfill their social missions. He is involved with Catalyst, a leading nonprofit focused on expanding opportunities for women in business. Kevin also supports Youth Eastside Services, one of the largest providers of youth and family counseling in the Seattle area. At Starbucks, Kevin is passionate about continuing to nurture what’s at the heart of the company’s success: human connection – the tens of millions of interactions large and small that happen between partners and customers every week, and make a meaningful difference in the communities around the world where Starbucks does business.
He graduated from New Mexico State University with a bachelor’s degree in Business Administration.
Twin Health was founded by Jahangir Mohammed, a serial inventor and entrepreneur, with a mission to reverse chronic diseases and help people live healthier and happier lives. Jahangir was the Founder/CEO of Jasper, which he helped build into a global market leader with Internet of Things (IoT) platforms. Currently used by over 10,000 enterprises around the world, Jasper was acquired by Cisco for $1.45B. Prior to Jasper, Jahangir was the Founder/CEO of Kineto Wireless, which pioneered the technologies to enable mobile phones to seamlessly use WiFi for voice and data. The technologies invented at Kineto became the basis for the UMA standard.
Jahangir is a prolific inventor with over 80 patents. He was named IoT Technology Pioneer at the World Economic Forum and was recognized for his visionary work and social impact by the Einstein Foundation. He was awarded an Honorary Doctorate by Concordia University, Canada.
Caroline Xie is a General Partner at ICONIQ investing in software, healthcare, and internet companies. Prior to ICONIQ, Caroline covered financial institutions and healthcare for Morgan Stanley in Hong Kong and California.
Caroline’s investments include Articulate, Benchling, Braze, Datadog (DDOG), GitLab, GoodRx (GDRX), Guild Education, Komodo Health, Moveworks, Nayya, QGenda, Reify Health, Relativity, Restaurant365, Sprinklr (CXM), Twin Health, Unite Us, and others.
As a Managing Director with Sequoia India, Mohit focuses on high growth companies in the Payments, Consumer Internet, and SaaS sectors.
He has served on the boards of Prizm Payments, Citrus Payments, Ujjivan Microfinance, Freshworks, Zomato, Circles.life, Near, DailyHunt, and One Assist, to name a few.
Prior to joining Sequoia, he was Senior Vice President at Bharti Airtel.
An entrepreneur at heart, Mohit co-founded Bright pod, a wireless start-up in the US, in the year 2000, by orchestrating a spin off from Ericsson Mobile Systems.
Mohit has an MBA from UNC Chapel Hill and an MSEE from Virginia Tech.
Ravi Lambah joined Temasek in 2012 and is currently Head, Strategic Initiatives and Head, India.
Prior to this role, he was Head of the Investment Group at Temasek. His past roles at Temasek
included Head of Temasek's Telecom, Media and Technology group and Joint Head of Southeast
Asia.
Before joining Temasek, Ravi was the Chief Operating Officer of ST Telemedia, a 100%
subsidiary of Temasek, STT is an investor-operator with a significant global portfolio of telecom
and media assets. His role comprised overseeing the investments and operations of the company.
Ravi has over 30 years in the investment and banking industry in the Asia-Pacific region, primarily
based out of Hong Kong and Singapore.
Ravi is a Chartered Accountant and a Cost and Management Accountant. He holds a Bachelor’s
degree in Commerce and Economics, from India’s University of Bombay.
Osama Hamdy, MD, PhD is a senior endocrinologist and Medical Director of the Joslin Obesity Clinical Program, and Director of the Inpatient Diabetes Program at Joslin Diabetes Center. He is also an Associate Professor of Medicine at Harvard Medical School. He is a world recognized expert and thought leader with 34 years of extensive clinical experience in nutrition and obesity research.
His lab led to innovations in how we manage obesity in patients with type 1 or type 2 diabetes. Dr. Hamdy’s research discovered that 7% weight loss in obese patients with and without diabetes significantly improves vascular endothelial function, insulin sensitivity and markers of inflammation. Dr. Hamdy was a co-investigator in landmark studies: the “Diabetes Prevention Program” and “the Look AHEAD Study.” Dr. Hamdy founded the “Weight Achievement and Intensive Treatment” (Why WAIT) program, helping patients with diabetes to be less dependent on diabetes medications. Dr. Hamdy co-chaired the task force that developed the global transcultural Diabetes Nutrition Algorithm (tDNA). His research led to changes in the standards of diabetes care and lifestyle management by the American Diabetes Association and the American Association of Clinical Endocrinologists.
Dr. Hamdy received the Michaela Modan Award of the American Diabetes Association and the Compassionate Caregiver Award of the Kenneth Schwartz Center. He has more than 150 peer-reviewed original articles, reviews and book chapters. He is also the author of the Harvard Health Publication “The Diabetes Breakthrough” reversing diabetes through weight management. He is on the editorial review board of many medical journals including Lancet, JAMA, British Medical Journal, Diabetes Care and Current Diabetes Report.
Elbert Huang, MD is Professor of Medicine and Public Health Sciences, Director of the Center for Chronic Disease Research and Policy, and Associate Director of the Chicago Center for Diabetes Translation Research at the University of Chicago. From 2010-2011, he served as a Senior Advisor in the Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services.
Dr. Huang is a general internist who studies clinical and health care policy issues at the intersection of diabetes, aging, and health economics. His main research focus is in the area of medical decision making for elderly patients with type 2 diabetes where uncertainty exists regarding how to best individualize diabetes treatments based on clinical parameters and patient preferences. Over the past two decades, Dr. Huang has established one of the most active research programs in geriatric diabetes in the country.
Dr. Huang’s research has been supported by the National Institutes of Health, the Centers for Disease Control and Prevention, the American Diabetes Association, and the Juvenile Diabetes Research Foundation. He has received numerous honors including the Research Paper of the Year Award from the Society of General Internal Medicine and elected membership to the American Society for Clinical Investigation.
Dr. Huang received his AB, MD, and MPH from Harvard University and came to the University of Chicago in 2001.
Francine R. Kaufman, MD is the Chief Medical Officer of Senseonics, Inc. (2019-present). Previously, she was the CMO and VP of Global Medical Affairs at Medtronic Diabetes (2009-2019). She is a Distinguished Professor Emerita of Pediatrics at the Keck School of Medicine of the University of Southern California. After joining the Division of Endocrinology at Children’s Hospital Los Angeles in 1980, she served as Director of Diabetes (1990-2001) and then Division Head of Endocrinology (2001-2009). She has authored over 290 peer-reviewed and invited articles, and numerous books including Diabesity (Bantam, 2005), The Medical Management of Type 1 Diabetes (ADA, 2008), The Insulin Pump and Continuous Glucose Monitoring Book: For Patients, Parents and Caregivers (ADA, 2012, 2017) and Rhythms (a novel) (CKI Publisher, 2015).
She has received numerous grants, including being funded by the NIH for over 3 decades. She was elected to the National Academy of Medicine in 2005. Dr. Kaufman was national president of the ADA (2002-2003). She directed diabetes camps in Southern California, Ecuador, and Haiti for over 30 years. She was instrumental in banning sodas from LA Unified School District in 2004.
Dr. Mechanick is a Professor of Medicine and Medical Director of The Marie-Josée and Henry R. Kravis Center for Cardiovascular Health at Mount Sinai Heart, and Director of Metabolic Support in the Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai. He received his M.D. degree from the Icahn School of Medicine at Mount Sinai, completed Internal Medicine residency at Baylor College of Medicine, and completed Endocrine Fellowship at The Mount Sinai Hospital. Dr. Mechanick authored over 386 publications in Endocrinology, Metabolism, and Nutrition Support with 272 PubMed citations currently.
He is the 2016-2017 Past President of the American College of Endocrinology, 2013-2014 Past President of the American Association of Clinical Endocrinologists, and 2005-2006 Past President of the American Board of Physician Nutrition Specialists. Dr. Mechanick co-edited Nutritional Strategies for the Diabetic and Prediabetic Patient; Power of Prevention: The Complete Guide to Lifelong Nutrition; Thyroid Cancer: From Emergent Biotechnology to Clinical Practice Guidelines; Molecular Nutrition – The Practical Guide, Lifestyle Medicine – A Manual for Clinical Practice, and Creating a Lifestyle Medicine Center; and co-authored Diabetes Mellitus Pocket and Nutritional Medicine Pocket.
Dr. Mechanick was appointed as a member of the President’s Council on Fitness, Sports and Nutrition (PCFSN) Science Board for 2010-2013 and was the 2013-2015 Editor-in-Chief and is currently Editor-in-Chief Emeritus of the PCFSN quarterly publication Elevate Health. Dr. Mechanick chairs the Physician Engagement Committee of the American Association for Parenteral and Enteral Nutrition. Dr. Mechanick also chairs the International Transcultural Diabetes Nutrition Algorithm Working Group. Dr. Mechanick currently serves as Chair of the Board of Visitors for the College of Computer, Mathematics, and Natural Sciences at the University of Maryland at College Park and was the 2011 recipient of the University of Maryland Industry Impact Award and 2011 University of Maryland Biology Alumnus Award. Dr. Mechanick’s research interests are in the fields of nutrition and metabolic support, obesity and lifestyle medicine, and network analysis of complex systems. Dr. Mechanick is responsible for training cardiology fellows at Mount Sinai Heart in preventive cardiology.
Ambrish Mithal, MD is an endocrinologist and the Chairman and Head of Endocrinology and Diabetes at Max Healthcare, Saket, New Delhi; he started working in December 2019. One of the most renowned names in the field of Endocrinology, Dr. Ambrish Mithal is considered to be a thought leader in the medical community. Before joining Max Healthcare, he was Chairman, Division of Endocrinology and Diabetes, at Medanta the Medicity. There, he led the Endocrinology and Diabetes division from 2009 to 2019. Before that, he worked at Apollo Hospital, New Delhi, and Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow.
More recently, in 2019, Dr. Mithal has been nominated to the Governing Council of the National Health Authority, the apex body involved in implementing the ambitious population health coverage plan of the government. He has also been appointed (honorary) President, All India Institute of Medical Sciences, Gorakhpur.
Dr. Mithal was awarded the International Osteoporosis Foundation President's Award in March 2016. In March 2017, Dr. Mithal was awarded the Dr. B C Roy Award by the President of India for his contribution to the development of endocrinology in India. He has won numerous awards from medical and social bodies throughout his career.
Rohit Satoskar, MD, is the Director of Medical Services for the MedStar Georgetown Transplant Institute. He is also medical director of Liver Transplantation and Associate professor in the Department of Medicine at the MedStar Georgetown Transplant Institute. An expert in hepatology and liver transplantation, Dr. Satoskar is board-certified in Internal Medicine, Gastroenterology and Transplant Hepatology. He is widely published and a frequent lecturer, regionally and nationally. In addition to Dr. Satoskar's role as a clinician, teacher and researcher, he is actively involved in public policy efforts to benefit patients with liver disease.
He serves in leadership positions with professional societies such as the American Association for the Study of Liver Diseases and the American Liver Foundation and is a founding board member of the Global Liver Institute dedicated to collaboration and innovation in dealing with liver disease. Dr. Satoskar is highly rated by patients for explaining things well, listening carefully, and treating patients with respect, among other things. He believes in personalized care for each patient to address their particular needs and help achieve the best possible outcome and quality of life. Each patient is cared for as an individual, using the latest evidence-based medicine and technology available.
Patrick Conway, MD, MSc, currently serves as the CEO of Care Solutions at Optum, part of UnitedHealth Group where he leads a portfolio of care continuum businesses with over $20 billion in annual revenue serving tens of millions of people across acute and post-acute care, care in the home in-person and virtually, mental and behavioral care benefits and delivery, broad population and complex disease health management, specialty care, and government health services.
From 2017-2019, he was President and CEO of Blue Cross and Blue Shield of North Carolina leading the organization to be recognized nationally for innovation, value-based payment, and investments in better health outcomes.
From 2011-17, Conway served as Deputy Administrator for Innovation and Quality at the federal Centers for Medicare and Medicaid Services (CMS) and as Director of the Center for Medicare and Medicaid Innovation (CMMI) and the agency’s Chief Medical Officer. Before joining CMS, he oversaw clinical operations and quality improvement at Cincinnati Children’s Hospital Medical Center. He remains a practicing pediatric hospitalist. A respected leader, innovator and clinician, he was elected to the National Academy of Medicine (NAM) in 2014, received the President’s Senior Executive Distinguished Service award, and was a White House Fellow in 2007-08.
Michelle Harika, PharmD, is a principal at Blackstone and Chief Clinical Officer for Equity Healthcare, where she is responsible for oversight and performance of a customized clinical model operated by multiple vendors. Dr. Harika also leads improvement initiatives designed to improve health, generate savings, and increase value to Blackstone’s portfolio companies. Before coming to Blackstone, Dr. Harika practiced pharmacy with a specialty in diabetes management, followed by 10 years with Anthem, where she was responsible for clinical program performance and improvement strategies.Dr. Harika serves on the advisory boards for HealthTrust’s PBM coalition and is a senior advisor for Tuft’s NewDIGs Initiative. She is an active participant in the Global Chief Medical & Health Officer Network Community and past president of the Central Virginia Association of Diabetes Educators. In addition to serving on the board of the Richmond Pharmacists Association, Dr. Harika volunteers as a member of the Virginia Medical Reserves Corp. Dr. Harika received her doctorate from the Medical College of Virginia School of Pharmacy.
Shashank Joshi, MD is Twin's chief scientist. As an endocrinologist and medical researcher, Dr. Joshi has extensive experience with the treatment and study of diabetes and chronic disease. Before joining Twin, he was the Chair of the South-East Asian International Diabetes Federation and president of several organizations: the Indian Academy of Diabetes, the Endocrine Society of India, the Association of Physicians of India, and the Research Society for Study of Diabetes in India. Dr. Joshi was a member of the faculty at Grant Medical College and Seth GS Medical College, where he earned his MBBS and MD, respectively. He is a fellow of the American College of Endocrinology, the American College of Physicians, and the Royal College of Physicians (London, Glasgow, and Edinburgh).
Dr. Joshi has published more than 800 research publications and Stanford University ranked him in the Top 0.5% of all scientists in General and Internal Medicine.
Frank Williams is the Co-Founder and Executive Chairman of Evolent Health (NYSE: EVH) and previously served as the company’s Chairman and CEO between 2011 and 2020. Frank also served as Chairman and CEO of The Advisory Board Company (NASDAQ: ABCO), a global research and technology firm that serves over 5,000 organizations across the healthcare and higher education sectors. During Frank's tenure as both its’ Chairman and CEO, The Advisory Board completed an initial public offering and grew to $450M+ in annual revenues with over 2,500 employees and $2B+ in market capitalization.
Along with the Evolent Health board, he currently serves on the boards of the Business Talent Group, Peer Health Exchange, Syapse and Passport Health Plan. Frank is active philanthropically in initiatives related to Public Health and Education. A native Californian, Frank received a BA in Political Economy from UC Berkeley and an MBA from Harvard Business School.
Ronald A. Williams is Chairman and CEO of RW2 Enterprises and the former Chairman and CEO of health insurance giant Aetna Inc. He’s the bestselling author of “Learning to Lead: The Journey to Leading Yourself, Leading Others, and Leading an Organization”.
Mr. Williams counsels C-Suite corporate executives on strategy and transformational leadership. As Operating Advisor to private equity firm Clayton Dubilier & Rice, he oversees portfolio companies including serving as Founding Chairman of agilon health and Chairman of Vera Whole Health. He previously served as Chairman of naviHealth and PharMedium. He is a Director of American Express, Boeing and Johnson & Johnson, and Warby Parker
Mr. Williams is Chairman of The Conference Board and member of President’s Circle of the National Academies, American Academy of Arts and Sciences and trustee of CED.
He’s a graduate of Roosevelt University and holds an M.S. in Management from MIT Sloan School of Management.
